These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37414358)

  • 21. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
    Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
    J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender-specific outcomes of low-dose computed tomography screening for lung cancer detection: A retrospective study in Chinese never-smoker population.
    Wang H; Xie J; Chen Y; Jin J; Zhang M; Tung T; Xu Y
    Cancer Med; 2024 Sep; 13(18):e70184. PubMed ID: 39342623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.
    Wei MN; Su Z; Wang JN; Gonzalez Mendez MJ; Yu XY; Liang H; Zhou QH; Fan YG; Qiao YL
    Thorac Cancer; 2020 May; 11(5):1224-1232. PubMed ID: 32196998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of low-dose computed tomography on lung cancer screening in high-risk populations: The experience over five screening rounds in Sichuan, China.
    Qiao L; Zhou P; Li B; Liu XX; Li LN; Chen YY; Ma J; Zhao YQ; Li TY; Li Q
    Cancer Epidemiol; 2020 Dec; 69():101801. PubMed ID: 33017728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
    Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
    Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of low-dose computed tomography compliance and related factors among high-risk population of lung cancer in three provinces participating in the cancer screening program in urban China].
    Wen Y; Yu LZ; Du LB; Wei DH; Liu YY; Yang ZY; Zheng YD; Wu Z; Yu XY; Zhao L; Yu YW; Chen HD; Ren JS; Qin C; Xu YJ; Cao W; Wang F; Li J; Tan FW; Dai M; Chen WQ; Li N; He J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 May; 55(5):633-639. PubMed ID: 34034404
    [No Abstract]   [Full Text] [Related]  

  • 27. Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen.
    Sverzellati N; Silva M; Calareso G; Galeone C; Marchianò A; Sestini S; Sozzi G; Pastorino U
    Eur Radiol; 2016 Nov; 26(11):3821-3829. PubMed ID: 26868497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung Cancer Screening with Low-Dose CT: a Meta-Analysis.
    Hoffman RM; Atallah RP; Struble RD; Badgett RG
    J Gen Intern Med; 2020 Oct; 35(10):3015-3025. PubMed ID: 32583338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Special issue "The advance of solid tumor research in China": Participants with a family history of cancer have a higher participation rate in low-dose computed tomography for lung cancer screening.
    Guo LW; Meng QC; Zheng LY; Chen Q; Liu Y; Xu HF; Kang RH; Zhang LY; Liu SZ; Sun XB; Zhang SK
    Int J Cancer; 2023 Jan; 152(1):7-14. PubMed ID: 35362560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung Cancer Screening With Low-dose Chest Computed Tomography: Experience From Radon-contaminated Regions in Kazakhstan.
    Panina A; Kaidarova D; Zholdybay Z; Ainakulova A; Amankulov J; Toleshbayev D; Zhakenova Z; Khozhayev A
    J Prev Med Public Health; 2022 May; 55(3):273-279. PubMed ID: 35678001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of low-dose computed tomography screening on lung cancer mortality among asbestos-exposed workers.
    Barbone F; Barbiero F; Belvedere O; Rosolen V; Giangreco M; Zanin T; Pisa FE; Meduri S; Follador A; Grossi F; Fasola G
    Int J Epidemiol; 2018 Dec; 47(6):1981-1991. PubMed ID: 30325420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
    Paci E; Puliti D; Lopes Pegna A; Carrozzi L; Picozzi G; Falaschi F; Pistelli F; Aquilini F; Ocello C; Zappa M; Carozzi FM; Mascalchi M;
    Thorax; 2017 Sep; 72(9):825-831. PubMed ID: 28377492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
    Fasola G; Belvedere O; Aita M; Zanin T; Follador A; Cassetti P; Meduri S; De Pangher V; Pignata G; Rosolen V; Barbone F; Grossi F
    Oncologist; 2007 Oct; 12(10):1215-24. PubMed ID: 17962615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening.
    Kim YW; Kwon BS; Lim SY; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Chung JH; Ji E; Lee CT
    Thorax; 2021 Oct; 76(10):980-988. PubMed ID: 33859050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of discrimination performance of 11 lung cancer risk models for predicting lung cancer in a prospective cohort of screening-age adults from Germany followed over 17 years.
    Bhardwaj M; Schöttker B; Holleczek B; Brenner H
    Lung Cancer; 2022 Dec; 174():83-90. PubMed ID: 36356492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort.
    de-Torres JP; Wisnivesky JP; Bastarrika G; Wilson DO; Celli BR; Zulueta JJ
    Arch Bronconeumol (Engl Ed); 2021 Jan; 57(1):36-41. PubMed ID: 32409195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of 10-year mobile low-dose computed tomography screenings for lung cancer in Shimane, Japan.
    Hamaguchi M; Tsubata Y; Tanino A; Mitarai Y; Hata K; Kobayashi M; Shiratsuki Y; Okuno T; Nakao M; Amano Y; Nakashima K; Hotta T; Hamaguchi S; Nagao T; Kurimoto N; Isobe T
    Respir Investig; 2022 Mar; 60(2):215-220. PubMed ID: 34740551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
    Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
    Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opportunistic lung cancer screening with low-dose computed tomography in National Cancer Center of China: The first 14 years' experience.
    Tang W; Liu L; Huang Y; Zhao S; Wang J; Liang M; Jin Y; Zhou L; Liu Y; Tang Y; Xu Z; Zhang K; Tan F; Bi N; Wang Z; Wang F; Li N; Wu N
    Cancer Med; 2024 Feb; 13(3):e6914. PubMed ID: 38234199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose computed tomography (LDCT) versus other cancer screenings in early diagnosis of lung cancer: A meta-analysis.
    Wang X; Liu H; Shen Y; Li W; Chen Y; Wang H
    Medicine (Baltimore); 2018 Jul; 97(27):e11233. PubMed ID: 29979385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.